Events2Join

bluebird bio Announces Pricing of Public Offering of Common Stock


bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

(Nasdaq: BLUE) (“bluebird”) today announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public offering price ...

bluebird bio Announces Pricing of Public Offering of Common Stock

Press Release ... CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 18, 2020-- bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public ...

bluebird bio Announces Pricing of Public Offering of Common Stock

The shares are being offered by bluebird bio pursuant to an automatically effective shelf registration statement that was previously filed with the Securities ...

Bluebird Bio announces pricing of public offering of common stock ...

* Bluebird Bio Inc - pricing of an underwritten public offering of 3.8 million shares of its common stock at a public offering price of $105.00 per share Source ...

bluebird bio Announces Pricing of Public Offering of Common Stock

bluebird bio anticipates the total gross proceeds from the offering (before deducting underwriters' discounts and commissions and estimated offering expenses) ...

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

(Nasdaq: BLUE) ("bluebird") today announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public ...

Bluebird Bio Announces Pricing Of Public Offering Of Common Stock

May 18 (Reuters) - bluebird bio Inc: * BLUEBIRD BIO ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK. * SAYS PUBLIC OFFERING OF 9.09 MILLION COMMON ...

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

bluebird bio, Inc. (Nasdaq: BLUE) announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public ...

bluebird bio Announces Pricing of Initial Public Offering

In addition, the underwriters have a 30-day option to purchase up to an additional 891,176 shares of common stock from bluebird bio. The company's shares are ...

bluebird bio announces pricing of underwritten public offering of ...

bluebird bio, Inc. announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public offering ...

bluebird bio, Inc. Announces Proposed Public Offering of Common ...

(Nasdaq: BLUE) has announced a public offering of $150,000,000 of its common stock, with an option for underwriters to purchase an additional ...

bluebird bio Announces Pricing of Public Offering of Common Stock ...

CAMBRIDGE, Mass. — bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public offering of 9090910 shares of its common stock at ...

bluebird bio Announces Pricing of Initial Public Offering - Forbion

... pricing of its initial public offering of 5941176 shares of common stock at a public offering price of $17.00 per share, before underwriting

bluebird bio, Inc. announces pricing of $120M public offering of ...

bluebird bio, Inc. today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock at a public ...

Blue Bird Announces Pricing of Secondary Public Offering

In addition, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to an additional 675,000 shares of Common ...

bluebird bio Announces Pricing of Public Offering of Common Stock ...

On May 18, 2020 bluebird bio, Inc. (Nasdaq: BLUE) reported the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a ...

bluebird bio (BLUE) Prices 83.33M Share Offering at $1.50/sh

bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock ...

bluebird bio proposes public offering of $150 million common stock

bluebird bio proposes public offering of $150 million common stock.

bluebird bio, Inc. Common Stock (BLUE) Press Releases - Nasdaq

Latest Press Releases · bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call · bluebird bio to Present Additional Long-Term ...

Bluebird Bio Hoping to Raise $250M in Public Offering of Common ...

The company plans to use the funds to commercialize and manufacture its three FDA-approved gene therapies, including Lyfgenia.